The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testing

BACKGROUND: HER2 status assessment is a prerequisite for the establishment of an appropriate treatment strategy in gastric cancer. Gastric cancers are very heterogeneous and separate evaluations of gene amplification and protein expression lead to uncertainties in localizing distinct clones and are...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Werner, Dominique, Battmann, Achim, Steinmetz, Kristina, Jones, Tobin, Lamb, Tiffany, Martinez, Michele, Altmannsberger, Hans-Michael, Al-Batran, Salah-Eddin
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4059883/
https://ncbi.nlm.nih.gov/pubmed/24906218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-160
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires